Fiche du document
2013
- doi: 10.1016/j.tcb.2013.08.006
- issn: 0962-8924
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.tcb.2013.08.006
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/24074947
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/1879-3088
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_B164E811B26B0
info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer
Sujets proches
Carcinoma Cancers Malignancy (Cancer) Malignant tumorsCiter ce document
S. Goruppi et al., « Mesenchymal stroma: primary determinant and therapeutic target for epithelial cancer. », Serveur académique Lausannois, ID : 10.1016/j.tcb.2013.08.006
Métriques
Partage / Export
Résumé
Multifocal and recurrent epithelial tumors, originating from either dormant or de novo cancer cells, are major causes of morbidity and mortality. The age-dependent increase of cancer incidence has long been assumed to result from the sequential accumulation of cancer-driving or -facilitating mutations with induction of cellular senescence as a protective mechanism. However, recent evidence suggests that the initiation and development of epithelial cancer results from a close interplay with its altered tissue microenvironment, with chronic inflammation, stromal senescence, autophagy, and the activation of cancer-associated fibroblasts (CAFs) playing possible primary roles. We will discuss recent progress in these areas, and highlight how this understanding may be used for devising novel preventive and therapeutic approaches to the epithelial cancer problem.